Background: Many muscarinic functions are relevant to anesthesia, and alterations in muscarinic activity affect the anesthetic/analgesic potency of various drugs. Volatile anesthetics have been shown to depress muscarinic receptor function, and inhibition of the muscarinic signaling pathway alters the minimal alveolar anesthetic concentration of inhaled anesthetics. The purpose of this investigation was to determine in a neuronal cell which source of Ca 2؉ underlying the carbachol-evoked transient increase in cytoplasmic Ca 2؉ was reduced by isoflurane.
MANY muscarinic functions are relevant to anesthesia and alterations in muscarinic activity affect the anesthetic/analgesic potency of various drugs. Brain stem muscarinic signaling modulates the level of consciousness, 1 whereas cortical muscarinic signaling affects memory and learning. 2, 3 Spinal muscarinic receptors inhibit glutamate release 4 and enhance ␥-aminobutyric acid release. 5 Muscarinic agonists have been reported to enhance antinociceptive effects, and this enhancement is blocked by pretreatment with M1, M2, or M3 muscarinic receptor antagonists or with antisense inhibition of M1 receptors. 6 -8 However, there are also reports indicating that muscarinic block enhances the analgesic/anesthetic action of various drugs, and that some of these drugs induce muscarinic block. 9, 10 Halothane and isoflurane have been shown to depress muscarinic receptor function, [11] [12] [13] [14] and inhibition of the muscarinic signaling pathway has been shown to have variable effects on the minimal alveolar anesthetic concentration of inhaled anesthetics. 15 Therefore, the role of muscarinic receptors in analgesia/anesthesia seems to be complex and can either augment or attenuate the anesthetic potency of the volatile anesthetics.
Muscarinic activation leads to a transient elevation of cytoplasmic Ca 2ϩ ([Ca 2ϩ ] cyt ) through Ca 2ϩ release from intracellular stores. We investigated the action of volatile anesthetics on the [Ca 2ϩ ] cyt transients evoked by a muscarinic agonist, carbachol, in human SH-SY5Y cells. We previously reported that halothane reduced the carbachol-evoked [Ca 2ϩ ] cyt transient in a concentration-dependent manner, and that sustained stimulation with KCl eliminated this effect of halothane. 16 The Ca 2ϩ contributing to the carbachol-evoked [Ca 2ϩ ] cyt transient seems to derive from both inositol tri-phosphate-sensitive and caffeine-sensitive Ca 2ϩ stores. 16 The purpose of this investigation was to determine which source of Ca 2ϩ underlying the carbachol-evoked [Ca 2ϩ ] cyt transient was reduced by isoflurane.
Materials and Methods

Cell Culture and Solutions
Experiments were performed on monolayers of SH-SY5Y human neuroblastoma cells (originally provided by June Biedler, Ph.D., Sloan-Kettering Institute for Cancer Research, Rye, NY at the providing time; Dr. Biedler is currently a Distinguished Resident Scientist, Fordham University, Bronx, NY), passages 60 -94. Cells were cultured in RPMI1640 medium with L-glutamine, supplemented with penicillin (50 U/ml), streptomycin (50 g/ml), and 12% fetal bovine serum at 37°C, in a humidified atmosphere containing 5% CO 2 . All cell culture components were Gibco BRL products purchased from Life Technologies (Rockville, MD). Cells were plated on glass coverslips (25-mm diameter) at a density of approximately 2-4 ϫ 10 4 cells/ml (2 ml/Petri dish) and used when they formed a confluent monolayer (i.e., between 8 -20 days after plating). The bath solution was a HEPES buffer containing (in mM) 140 NaCl, 5 KCl, 5 NaHCO 3 , 10 HEPES, 1 MgCl 2 , 1.5 CaCl 2 , 1 ATP, and 10 glucose (pH 7.4). All experiments were performed at 37°C, and the temperature was controlled with a Dual Heater controller TC-344A and an inline heater SH-27B (Warner Instruments Inc., Hamden CT). All the solutions and instruments were prewarmed to 37°C before being used. The exchange of the solution was done using a manifold, with its common outlet placed in the entrance of the heater inline. The solutions containing [200 mM] KCl (EM-Science), [10 mM] caffeine, [1 mM] carbachol, or [200 M] ryanodine were prepared using the HEPES buffer. Saturated isoflurane (Ohmeda Caribe Inc., Guayana, PR) solutions were prepared in HEPES buffer 24 h in advance in gas-tight containers and diluted to the final concentration (1 mM) immediately before used as previously described. 16 Ca 2ϩ Measurements SH-SY5Y cells were loaded with the fluorescent Ca 2ϩ indicator Fura-2 17 by incubating the cells on coverslips in the culture medium containing 5 M of the acetoxymethyl ester of the dye (Fura-2 AM; Molecular Probes, Eugene, OR) for 30 min under culture conditions. 16 After loading, cells were gently washed three times with the HEPES buffer, and the coverslips were placed into the perfusion chamber and perfused (250 l/min) for 30 min with the buffer at 37°C to allow their equilibration with the experimental environment before being exposed to the various drugs. The bath solution alone and containing the individual or combination of drugs was perfused at 250 l/min for various periods as indicated in the figure legends.
The perfusion chamber was set on an inverted microscope (DIAPHOT 300; Nikon, Melville, NY) equipped with a ϫ40 oil-immersion objective (N.A.1.30, Nikon). The microscope was attached to a high-speed multiwavelength illuminator (DeltaRAM V; Photon Technology International, Inc., PTI, Lawrenceville, NJ). The excitation wavelengths for Fura-2 (340 nm and 380 nm) were alternately (every 0.02 s) generated with a monochromator. The emitted fluorescence (from the alternated excitation at 340 and 380 nm) from 15-20 cells was filtered with the fluorescence barrier filter BA 515 nm, collected with a photomultiplier (PMT01-710, Photon Technology International), and digitized at 50 Hz.
Data Analysis
Data collection and analysis was carried out with Felix (version 1.42a, Photon Technology International) and Clampfit (Pclamp 8; Axon Instruments, Foster City, CA) software. For each treatment (corresponding to data in each figure) , experiments were performed under different conditions on sister cultures (same plating day) and on three to five culture sets (different plating days). The averaged traces shown in the figures were obtained by lining up the peak values for the evoked [Ca 2ϩ ] cyt transients. Unless otherwise indicated, the areas were obtained over a period of 300 s starting from the onset of the carbachol-evoked [Ca 2ϩ ] cyt transient on each trace.
In the figures, the data represent the ratio (in protocols and steady states) or the ⌬ ratio (for peak and areas) of the emission of Fura-2 at 515 nm obtained with 340 and 380 nm excitations (ratio 340/380). Control steady-state levels were measured just before the addition of any compound, and the new steady-state level after the addition of a particular compound was measured just before the addition of the subsequent compound. Steadystate levels measurements are expressed as ratio (340/ 380) values.
Statistical Analysis
Comparison between different groups was performed using the unpaired or paired two-tailed t test with Sigma software (Jandel Scientific Corp., San Rafael, CA). 
Results
Atropine Blocked the Carbachol-evoked [Ca 2ϩ ] cyt Transient
Atropine (1 M), a muscarinic blocker, completely (Ͼ99%) blocked the main peak of the carbachol-evoked [Ca 2ϩ ] cyt transient ( fig. 1, 90 Figure 2 shows the averaged response for the carbacholevoked [Ca 2ϩ ] cyt transient before and after the exposure to 1 mM isoflurane. Isoflurane significantly reduced the peak and the area of the carbachol-evoked [Ca 2ϩ ] cyt transient ( fig. 2A 2C ). However, continuous KCl stimulation produced a large increase in the [Ca 2ϩ ] cyt steadystate level, and this increase was attenuated by isoflurane ( fig. 2F ). Isoflurane also reduced the peak and area values of the KCl-evoked [Ca 2ϩ ] cyt transient ( fig. 3 ). We previously reported that isoflurane had a biphasic concentration-dependent effect on the KCl-evoked [Ca 2ϩ ] cyt transient, increasing the transient at low concentrations and decreasing it at higher concentrations. 16 In our previous study, 1 mM isoflurane produced no significant change compared with the control value, 16 cells were grown (high-density confluent multilayer 16 vs. monolayer). However, in both studies it is clear that continuos treatment with KCl eliminated the inhibition by both halothane 16 and isoflurane (present study) of the carbachol-evoked [Ca 2ϩ ] cyt response.
Isoflurane-mediated Reduction of the Carbacholevoked [Ca 2ϩ ] cyt Transient Required Full Caffeinesensitive Ca 2ϩ Stores
We then investigated whether a direct depletion of the caffeine-sensitive Ca 2ϩ stores could also eliminate the isoflurane-mediated reduction of the carbachol-evoked [Ca 2ϩ ] cyt transient. We previously showed that the carbachol-evoked [Ca 2ϩ ] cyt transient involves Ca 2ϩ release mostly from the inositol tri-phosphate-sensitive Ca 2ϩ store but also from caffeine-sensitive stores. 16 In this study, we found that pretreatment with 10 mM caffeine reduced the carbachol-evoked [Ca 2ϩ ] cyt response ( fig.  4A vs. fig. 2A, controls) . In the presence of caffeine, isoflurane did not produce an additional reduction of the carbachol-evoked [Ca 2ϩ ] cyt response ( fig. 4 ), suggesting that this action of isoflurane requires a full caffeinesensitive Ca 2ϩ store. The steady-state level of [Ca 2ϩ ] cyt was not affected by isoflurane or caffeine when added individually, and it only displayed a slightly significant increase when they were applied together ( fig. 4C ). figure 2F . Asterisks indicate a statistically significant difference (P < 0.001, unpaired t test) between control and isoflurane conditions.
Fig. 3. Isoflurane reduces the KCl-evoked [Ca 2؉ ] cyt transient. The conditions are the same as described in figure 1B. (A) The averaged KCl-evoked [Ca 2؉ ] cyt transients in the absence and presence of 1 mM isoflurane (ISO). (B) The mean peak and area values for the KCl-evoked [Ca 2؉ ] cyt transients in the absence and presence of isoflurane. The corresponding steady-state levels of [Ca 2؉ ] cyt are shown in
Fig. 4. Caffeine treatment eliminates isoflurane-mediated reduction of the carbachol-evoked [Ca 2؉ ] cyt transient. Cells were exposed to 1 mM carbachol (CAB) for 2 min in the presence of 10 mM caffeine (CAF) and in the absence or presence of 1 mM isoflurane (ISO). The application of isoflurane was started 10 min before the carbachol stimulation, and the application of caffeine was started 5 min before the carbachol stimulation. (A) The averaged carbachol-evoked [Ca 2؉ ] cyt transient in the absence and presence of isoflurane. (B) The mean peak and area values for the carbachol-evoked [Ca 2؉ ] cyt transient in the absence and presence of isoflurane. (C) The corresponding steady-state levels of [Ca 2؉ ] cyt . Asterisk indicates a statistically significant difference (P < 0.05, unpaired t test) between control and a given group.
Isoflurane-mediated Reduction of the Carbacholevoked [Ca 2ϩ ] cyt Transient Required Ca 2ϩ Release from the Caffeine-sensitive Store through the Ryanodine-sensitive Ca 2ϩ Release Channels
To test whether the isoflurane-mediated reduction of the carbachol-evoked [Ca 2ϩ ] cyt required Ca 2ϩ release from caffeine-sensitive store through ryanodine-sensitive Ca 2ϩ release channels, we blocked ryanodine-sensitive Ca 2ϩ release channels by exposing the cells to 200 M ryanodine. Because activation of Ca 2ϩ release channels is required to obtain maximal channel block by ryanodine, 18, 19 the following protocol was developed. Cells were pretreated for 5 min with ryanodine, exposed to a short KCl pulse (to activate ryanodine-sensitive Ca 2ϩ release channels), and after 18 min (time required for Ca 2ϩ refilling of intracellular Ca 2ϩ stores) exposed to carbachol. The level of channel block was determined by measuring the ryanodine action on two consecutive KCl-evoked [Ca 2ϩ ] cyt transients ( fig. 5 ). When cells were exposed to ryanodine, the initial response was an increase in the [Ca 2ϩ ] cyt ( fig. 5, arrow) , which has been reported to reflect activation of ryanodine-sensitive Ca 2ϩ channels. 19, 20 Ryanodine showed only a small blocking effect on the first KCl-evoked [Ca 2ϩ ] cyt response ( fig. 5C,  1st) , even when cells were exposed to ryanodine for 48 h (data not shown); however, ryanodine strongly blocked the second KCl-evoked [Ca 2ϩ ] cyt response ( fig.  5C, 2nd) . In contrast to the continuous exposure to KCl (fig. 2D ), the KCl pulse did not eliminate the isofluranemediated reduction of the carbachol-evoked [Ca 2ϩ ] cyt transient ( fig. 6 ); although the isoflurane-mediated area reduction was significant, the peak reduction did not reach a significant level ( fig. 6A and B) . Ryanodine pretreatment did not significantly decrease the carbacholevoked [Ca 2ϩ ] cyt response (peak or area) ( fig. 6A and B , control vs. fig. 6D and E, control) , in contrast to continuous exposure to KCl (fig. 2B , control vs. E, control) or caffeine treatment ( fig. 4B, control vs. fig. 2B, control) . However, ryanodine pretreatment still eliminated the isoflurane-mediated reduction of the carbachol-evoked [Ca 2ϩ ] cyt transient ( fig. 6D and E) , suggesting that the isoflurane-mediated reduction of the carbachol-evoked [Ca 2ϩ ] cyt transient requires Ca 2ϩ release from the caffeine-sensitive Ca 2ϩ stores through ryanodine-sensitive Ca 2ϩ -release channels. The steady-state level of [Ca 2ϩ ] cyt was slightly increased after the KCl pulse ( fig. 6C ) or after ryanodine pretreatment ( fig. 6F ); under both of these conditions, the addition of isoflurane did not produce additional changes in the steady-state level of [Ca 2ϩ ] cyt ( fig. 6C and F ).
Discussion
The purpose of this study was to determine the intracellular source of the portion of the carbachol-evoked [Ca 2ϩ ] cyt transient that was reduced by volatile anesthetics. Our previous work suggested that this portion of Ca 2ϩ was derived from the caffeine-sensitive Ca 2ϩ store. 16 We have demonstrated in this study that the portion of the carbachol-evoked [Ca 2ϩ ] cyt transient that is reduced by halothane is also reduced by isoflurane, that it arises from the caffeine-sensitive Ca 2ϩ store, and that it is released from the caffeine-sensitive store through ryanodine-sensitive Ca 2ϩ release channels.
The role of muscarinic receptors in analgesia/anesthesia is complex because, as discussed previously, both activation and blockade of muscarinic receptors have been shown to be analgesic. Our results indicate that, at the concentrations used, isoflurane blocks only part of the carbachol-evoked [Ca 2ϩ ] cyt response, apparently at site that is distal to the muscarinic receptor. This isoflurane-sensitive component may be contributing to the anesthetic potency of isoflurane. The previously reported variable effects of muscarinic blockers on the minimum alveolar concentration of inhaled anesthetics could reflect differences in the magnitude of this isoflurane-sensitive component in various brain/spinal regions, where the muscarinic blockers were applied.
The experiments with caffeine show that the isoflurane-mediated blocking action on the carbachol-evoked [Ca 2ϩ ] cyt transient requires that caffeine-sensitive Ca 2ϩ stores are not depleted. We show that ryanodine at 200 M, which is known to be a maximal blocking concentration, 19, 21 reduces the KCl-evoked [Ca 2ϩ ] cyt response by 50% without reducing the carbachol-evoked [Ca 2ϩ ] cyt response, and eliminates the isoflurane-medi- ated blocking effect on the carbachol-evoked [Ca 2ϩ ] cyt transient. This finding indicates that Ca 2ϩ release through ryanodine channels is required for the isoflurane-mediated blocking action on the carbachol-evoked [Ca 2ϩ ] cyt transient. There are several possible explanations for the mechanism by which isoflurane and halothane may reduce the carbachol-evoked [Ca 2ϩ ] cyt transient. One possibility is that isoflurane and halothane actually block the opening of the ryanodine-sensitive Ca 2ϩ release channel; however, this appears unlikely because halothane, 22 and perhaps isoflurane, 16 actually enhance the opening of the ryanodine-sensitive Ca 2ϩ release channel. A second possibility is that isoflurane decreases the level of Ca 2ϩ in the caffeine-sensitive Ca 2ϩ stores by enhancing Ca 2ϩ release through ryanodinesensitive Ca 2ϩ channels. However, further experiments are required to determine whether the isoflurane action on the carbachol-evoked [Ca 2ϩ ] cyt transient results from a direct or indirect action of isoflurane on the ryanodinesensitive Ca 2ϩ channels. As an indirect action, Ca 2ϩ is released from the caffeine-sensitive stores and shuttled to the inositol tri-phosphate-sensitive stores through volatile-anesthetic-sensitive transporters (e.g., similar to the binding of Ca 2ϩ , entering through L-type Ca 2ϩ channels, to calmodulin), 23, 24 or Ca 2ϩ could be released from the caffeine-sensitive stores and inhibits a volatile-anestheticsensitive channel (e.g., capacitative channels at the plasma membrane). In addition, Ca 2ϩ released through the ryanodine-sensitive Ca 2ϩ channels could be in close vicinity to Ca 2ϩ transport systems that are activated by volatile anesthetics such as the sarco/endoplasmic reticulum Ca 2ϩ -pumping adenosine triphosphatase. 25 At this time there is no evidence to implicate any of these or other possible mechanisms. In SH-SY5Y cells, muscarinic agonists increase [Ca 2ϩ ] cyt and the level of inositol triphosphate, 26 and in smooth muscle cells halothane decreases the carbachol-evoked [Ca 2ϩ ] cyt increase and reduces inositol tri-phosphate production. 27 Therefore, isoflurane may inhibit the carbachol-evoked [Ca 2ϩ ] cyt transient by reducing the inositol tri-phosphate production. However, a decrease in the inositol tri-phosphate production or any direct isoflurane action on muscarinic receptors (even if they take place) would not explain our observations. If the latter actions were responsible for the isoflurane-mediated decrease in the carbachol evoked [Ca 2ϩ ] cyt transient, the isoflurane effect under the various conditions studied (continuous KCl, ryanodine or caffeine treatment) would still be expected.
In summary, this study shows that isoflurane interferes with muscarinic-evoked [Ca 2ϩ ] cyt transients through a mechanism downstream from the muscarinic receptors. Isoflurane reduces the carbachol-evoked [Ca 2ϩ ] cyt transient. The carbachol-evoked [Ca 2ϩ ] cyt transient is dependent on Ca 2ϩ derived from both inositol tri-phosphateand caffeine-sensitive Ca 2ϩ stores. Reduction of the carbachol-evoked [Ca 2ϩ ] cyt transient by isoflurane is eliminated either when the caffeine-sensitive Ca 2ϩ store is depleted or when the release of Ca 2ϩ from the caffeinesensitive Ca 2ϩ store is blocked by ryanodine. The relationship between the modulation of Ca 2ϩ homeostasis by volatile anesthetics and the mechanisms of anesthesia remains unclear and must be examined in more complex systems.
